Perceptive Advisors LLC Gilead Sciences, Inc. Transaction History

Perceptive Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $109 Million - $126 Million	-1,500,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $93.9 Million - $120 Million	1,500,000 New	1,500,000 $11.2 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $2.85 Million - $3.34 Million	-40,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $2.88 Million - $3.42 Million	40,000	40,000 $3.24 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.